NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 36 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $804 | +11.2% | 8,937 | +13.7% | 0.00% | – |
| Q2 2023 | $723 | +36050.0% | 7,857 | -0.7% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 7,911 | +0.1% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 7,900 | -6.2% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 8,424 | +246.8% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 2,429 | -39.9% | 0.00% | – |
| Q1 2022 | $3,000 | -50.0% | 4,042 | -27.9% | 0.00% | – |
| Q4 2021 | $6,000 | -45.5% | 5,608 | -12.3% | 0.00% | – |
| Q3 2021 | $11,000 | +450.0% | 6,394 | +716.6% | 0.00% | – |
| Q1 2021 | $2,000 | -50.0% | 783 | -40.5% | 0.00% | – |
| Q3 2020 | $4,000 | -71.4% | 1,317 | -63.0% | 0.00% | -100.0% |
| Q2 2020 | $14,000 | – | 3,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 52,926 | $113,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 109,940 | $236,000 | 0.01% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $22,000 | 0.00% |
| Sowell Financial Services LLC | 11,190 | $24,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 101,949 | $219,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 32,822 | $71,000 | 0.00% |
| UBS Group AG | 816 | $2,000 | 0.00% |
| IFP Advisors, Inc | 50 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 6 | $0 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $2,000 | 0.00% |